ANGLE plc (GB:AGL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ANGLE plc has unveiled promising new data at the AACR Special Conference, highlighting the development of a Parsortix-based HER2 assay kit for metastatic breast cancer patients. This innovative solution allows for the continuous assessment of HER2 status, potentially identifying patients who could benefit from targeted therapies. The study revealed significant cases where HER2 status changed over time, underscoring the potential of this assay in personalized cancer treatment.
For further insights into GB:AGL stock, check out TipRanks’ Stock Analysis page.
